News Archives

News Archives

Avivagen Adds to Executive Team and Announces the Exercise of Warrants

Ottawa, ON / TNW-Accesswire / Feb 21 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a life sciences company commercializing products intended to replace the antibiotics added to livestock feeds, announces the appointment of Mr. Drew Basek as Director of Investor Relations and Mr. Louis Hui as Director of Business Development. Mr. Drew …Read More

Avivagen Changes Leadership Team in Preparation for Global Scale Up and Commercialization

Focus is on Market Access and Market Penetration for Antibiotic Replacement in Livestock Feed Application Ottawa, ON / TNW-Accesswire / Feb 9 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF, “Avivagen” or the “Company”), a life sciences company commercializing products intended to replace the antibiotics added to livestock feed, today announces that the …Read More

Avivagen Undertakes Human Health Proof-of-Concept

Ottawa, ON / TNW-Accesswire / Feb 3 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a life sciences company commercializing products intended to replace the antibiotics added to livestock feeds, announces a project to establish proof-of-concept for a first human health application of its technology ‒ with the help of the National Research …Read More